Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation [2]

International Journal of Hematology

Volumn 81, Issue 5, 2005, Pages 439-440

  Mori, Takehiko ^a   Aisa, Yoshinobu ^a   Nakazato, Tomonori ^a   Ikeda, Yasuo ^a   Okamoto, Shinichiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYMOCYTE ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIMICROBIAL THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DONOR; DRUG DOSE REGIMEN; HIGH RISK PATIENT; HUMAN; LETTER; PATIENT MONITORING; RISK ADAPTED PREEMPTIVE THERAPY; RISK FACTOR;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PREMEDICATION; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 21444434397     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05036     Document Type: Letter

References (5)

1. Choi S-M, Lee D-G, Choi J-H, et al. Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea. Int J Hematol. 2005;81:69-74.
2. Mori T, Okamoto S, Matsuoka S, et al. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000;25:765-769.
3. Kanda Y, Mineishi S, Nakai K, Saito T, Tanosaki R, Takaue Y. Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin. Blood. 2001;97:3676-3677.
4. Nakai K, Kanda Y, Mineishi S, et al. Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin. Bone Marrow Transplant. 2002;29:237-241.
5. Mori T, Okamoto S, Watanabe R, et al. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:777-782.